Minder System Cleared for Patients 12 -75 Years of Age
Filed with ASX · · 3 pages · English
Summary by 6ix AI
This clearance allows for continuous EEG monitoring in adolescents, addressing a significant gap in access to necessary treatment for this vulnerable population. The Minder System is a minimally invasive device that provides long-term monitoring of brain activity, which can now be utilized by US clinicians for teenage patients.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Epiminder
- FY27 YTD operational update and AGM materials
- Quarterly Activities/Appendix 4C Cash Flow Report
- 100th patient enrolled in US study ahead of schedule
- Updated Securities Trading Policy
- Change of Director's Interest Notice DO
Later from Epiminder
- Results of Annual General Meeting
- Change of Address
- Resignation of Chief Financial Officer
- CMS Increases Medicare Payment for the Minder System CY 2027
Follow Epiminder into a list and get an email when it puts out news.
Follow Epiminder